Region Oerebro Laen — Sponsor Intelligence | 9 EU Trials

Filter these 9 trials by condition, phase, country and more.

Open in Search →

9 Registered trials

6 Recruiting

2 Completed trials

12 Countries active

21 Unique IMPs

100% Results reported

Phase III

Phase II

Phase III/IV

Phase IV

Phase III: 2 Phase II: 1 Phase III/IV: 2 Phase IV: 4

100%

2 of 2 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top IMPs

ABEMACICLIB 1 ANASTROZOLE 1 B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), INFLUENZA VIRUS A/DARWIN/9/2021 SAN-010 (H3N2), INFLUENZA VIRUS B/MICHIGAN/01/2021, INFLUENZA A/VICTORIA/4897/2022 IVR-238 (H1N1), INACTIVATED 1 DAPAGLIFLOZIN 1 EXEMESTANE 1 FULVESTRANT 1 LETROZOLE 1 METOPROLOL TARTRATE 1 PALBOCICLIB 1 RIBOCICLIB 1 SODIUM CHLORIDE 1

All trials

9 total

General Anaesthesia vs Spinal anaesthesia: Patient outcomes and Success in outpatient primary total knee and hip arthroplasty. Pending

2024-520127-89-00 Phase IV 1 country
First-line catheter ablation for early treatment of Persistent (ongoing unless cardioverted) Atrial Fibrillation (AF) – a randomized study … Recruiting

2023-505962-28-00 Phase III 7 countries
Optimizing endocrine treatment > 5 years after surgery for breast cancer patients: a registry-based randomized clinical trial Recruiting

2023-506135-14-00 Phase III/IV 1 country
Klonidin as pain relief in eye examination of premature infants - cloROP Recruiting

2024-512438-14-00 Phase IV 1 country
Effect of infLuenza vaccInation after Myocardial INfArction on cardiac inflammaTory responsE - a randomized, double-blind, placebo-controlle… Recruiting

2023-505361-86-00 Phase IV 2 countries B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), INFLUENZA VIRUS A…
SGLT2 inhibitor TrEatment iN patients awaiting cOronary arTery bYpass surgery to reduce Post-opErative atrial fibrillation and kidney injury… Recruiting

2023-505375-75-00 Phase III 3 countries DAPAGLIFLOZIN
IMPlementing geriatric assessment for dose Optimization of CDK 4/6-inhibitors in older bReasT cAncer patieNTs – a pragmatic randomized-contr… Recruiting

2023-506620-87-00 Phase III/IV 6 countries ABEMACICLIB; ANASTROZOLE; EXEMESTANE; FULVESTRANT; LETROZOLE; PALBOCICLIB; RIBOC…
A randomized controlled trial with Rituximab for Psychotic disorder in adults Ended

2024-512408-20-00 Phase II 1 country
Beta-blockeRs tO patieNts with CHronIc Obstructive puLmonary diseasE (BRONCHIOLE) Ended

2024-512407-39-00 Phase IV 1 country METOPROLOL TARTRATE

Showing 1–9 of 9 trials

← All sponsors A–Z